XML 64 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
 12 Months Ended
Sep. 28, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Summary of Stock Options
Shares Under
Option		Weighted
Average Exercise
Price Per Share		Weighted Average Remaining Contractual Life (in Years)Aggregate
Intrinsic Value
(in millions)
Outstanding, September 30, 20236,380,008 $67.65 
Exercised(364,720)39.85 
Forfeited or expired(973,021)64.28 
Granted2,072,396 48.74 
Outstanding, September 28, 20247,114,663 $64.02 6.4$26 
Exercisable, September 28, 20244,685,557 $68.62 5.2$8 
Schedule of Assumptions of Fair Value Calculation of Each Year's Grants Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.
202420232022
Expected life (in years)4.54.54.4
Risk-free interest rate4.5 %3.9 %1.1 %
Expected volatility31.9 %31.2 %30.0 %
Expected dividend yield2.7 %2.9 %2.4 %
Schedule of Summary of Restricted Stock
Number of SharesWeighted
Average Grant-
Date Fair Value
Per Share		Weighted Average
Remaining
Contractual Life
(in Years)		Aggregate
Intrinsic Value
(in millions)
Nonvested, September 30, 20231,635,915 $67.20 
Granted1,072,563 50.51 
Dividends34,667 49.42 
Vested(644,324)64.40 
Forfeited(232,230)58.37 
Nonvested, September 28, 20241,866,591 $59.35 1.6$111 
Schedule of Summary of Performance-Based Shares
The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.
Number of SharesWeighted
Average Grant-
Date Fair Value
Per Share		Weighted Average
Remaining
Contractual Life
(in Years)		Aggregate
Intrinsic Value
(in millions)
Nonvested, September 30, 20231,646,149 $51.81 
Granted1,632,796 40.09 
Vested(268,707)60.99 
Forfeited(634,936)37.36 
Nonvested, September 28, 20242,375,302 $46.57 1.5$142